Postes actifs de Sylvain Guénette
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
TALLC Corp., Inc.
 TALLC Corp., Inc. Pharmaceuticals: MajorHealth Technology TALLC Corp, Inc. operates as a pre-clinical stage pharmaceutical company. It focuses on the development of TA-A001, a novel endocannabinoid CB2 receptor activator with potent anti-inflammatory analgesic properties. The company was founded by Damon Smith, Melanie Kelly and Guy Chamberland and is headquartered in Laval, Canada. | Directeur/Membre du Conseil | - | - |
| Directeur Financier/CFO | - | - |
Historique de carrière de Sylvain Guénette
Anciens postes connus de Sylvain Guénette
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Labopharm, Inc.
 Labopharm, Inc. BiotechnologyHealth Technology Labopharm, Inc. discovers and develops drugs. The company was founded in 1990 and is headquartered in Montreal, Canada. | Comptroller/Controller/Auditor | 23/03/2011 | - |
| Directeur Financier/CFO | 23/03/2011 | - |
Statistiques
Internationale
| Canada | 3 |
Opérationnelle
| Director of Finance/CFO | 2 |
| Comptroller/Controller/Auditor | 1 |
| Director/Board Member | 1 |
Sectorielle
| Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Labopharm, Inc.
Labopharm, Inc. BiotechnologyHealth Technology Labopharm, Inc. discovers and develops drugs. The company was founded in 1990 and is headquartered in Montreal, Canada. | Health Technology |
TALLC Corp., Inc.
TALLC Corp., Inc. Pharmaceuticals: MajorHealth Technology TALLC Corp, Inc. operates as a pre-clinical stage pharmaceutical company. It focuses on the development of TA-A001, a novel endocannabinoid CB2 receptor activator with potent anti-inflammatory analgesic properties. The company was founded by Damon Smith, Melanie Kelly and Guy Chamberland and is headquartered in Laval, Canada. | Health Technology |
- Bourse
- Insiders
- Sylvain Guénette
- Expérience
